Search

1. The "deemed to be a license" provision of the BPCI Act: questions and answers

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2020

Subject(s):

Biological Products
Drug Approval
Licensure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

2. "I swear by Apollo physician--": Greek medicine from the gods to Galen

Publication:

[Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health, 2002]

Subject(s):

History of Medicine
Exhibitions as Topic
History, Ancient
Greece, Ancient
Galen.

3. ["Tree of Hippocrates" plaque]

Author(s):

Greenberg, Stephen J., photographer

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, [2017]

Subject(s):

Trees
National Library of Medicine (U.S.)

4. The 'New Federalism' and Public Health: Keynote Address to the 18th Annual Conference of the New England Public Health Association, Wychmere Harbor, Cape Cod, Massachusetts [Reminiscence]

Publication:

Produced: 2003

Archival Collection:

The C. Everett Koop Papers (Profiles in Science)

5. The 2018 long-term budget outlook

Publication:

Washington, D.C. : Congressional Budget Office, June 2018

Subject(s):

Budgets -- trends
Federal Government
United States

6. The 2019 long-term budget outlook

Publication:

[Washington, DC] : Congressional Budget Office, June 2019

Subject(s):

Budgets -- trends
Gross Domestic Product -- trends
United States

7. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, December 16, 2019

Subject(s):

Device Approval -- standards
Equipment and Supplies -- standards
Manufactured Materials -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

8. 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, January 2020

Subject(s):

Drug Costs -- legislation & jurisprudence
Government Regulation
Medicaid -- economics
United States
United States. Department of Health and Human Services

9. 510(k) third party review program: guidance for industry, Food and Drug Administration staff, and third party review organizations

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, March 12, 2020

Subject(s):

Device Approval
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

10. ACF cannot ensure that all child victims of abuse and neglect have court representation

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021

Subject(s):

Child Abuse -- legislation & jurisprudence
Child Protective Services -- standards
Government Regulation
Legal Services -- organization & administration
United States
United States. Department of Health and Human Services

11. ACF should improve oversight of head start to better protect children’s safety

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Child Health
Government Regulation
Early Intervention, Educational
United States
United States. Administration for Children and Families

12. ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019

Subject(s):

Accountable Care Organizations -- economics
Cost Savings
Medicare -- economics
Quality of Health Care
Value-Based Purchasing
United States

13. ANDA submissions--amendments to abbreviated new drug applications under GDUFA

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Drugs, Generic -- standards
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

14. ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2020

Subject(s):

Drug Approval
Drug Industry
Drugs, Generic
Therapeutic Equivalency
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

15. ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2021

Subject(s):

Chemistry Techniques, Synthetic
DNA, Ribosomal
Drug Approval
Drugs, Generic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

16. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

Publication:

Washington, DC : United States Government Accountability Office, December 2022

Subject(s):

Elder Abuse -- legislation & jurisprudence
Government Regulation
Hospice Care -- legislation & jurisprudence
Legislation, Medical
Mandatory Reporting
Medicaid -- organization & administration
Medicare -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

17. Accelerating adoption of assistive technology to reduce physical strain among family caregivers of the chronically disabled elderly living at home

Author(s):

Lewin Group, author.

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Assistant Secretary for Planning and Evaluation, Office of Disability, Aging and Long-Term Care Policy, January 14, 2012

Subject(s):

Caregivers
Self-Help Devices -- statistics & numerical data
Aged
Persons with Disabilities
Respite Care
United States
National Family Caregiver Support Program (U.S.)

18. Acceptance and filing reviews for premarket approval applications (PMAs): guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, December 16, 2019

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

19. Access and use of electronic health information by individuals with cancer: 2017-2018

Author(s):

Johnson, Christian, MPH, author
Krakow, Melinda, author
Patel, Vaishali, author

Publication:

Washington, DC : U.S. Department of Health and Human Services, Office of the National Coordinator for Health Information Technology, January 2020

Subject(s):

Electronic Health Records -- statistics & numerical data
Facilities and Services Utilization -- statistics & numerical data
Health Services Accessibility -- statistics & numerical data
Neoplasms
United States
United States. Department of Health and Human Services

20. Access to Medicare Part D plans: a comparison of metropolitan and nonmetropolitan areas

Author(s):

Nataliansyah, Mochamad, author
Salako, Abiodun, author
Ullrich, Fred, author
Mueller, Keith, author

Publication:

Iowa City, IA : Rural Policy Research Institute, May 2020

Subject(s):

Medicare Part D -- statistics & numerical data
Rural Population
Urban Population
United States